Singular Genomics Systems, Inc. (OMIC)

NASDAQ: OMIC · IEX Real-Time Price · USD

0.389

+0.002 (0.49%)

At close: Apr 18, 2024, 4:00 PM

0.399

+0.010 (2.49%)

After-hours: Apr 18, 2024, 5:40 PM EDT

Singular Genomics Systems Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	2.91	0.77	0	0	0
Revenue Growth (YoY)	280.52%	-	-	-	-
Cost of Revenue	3.47	0.79	0	0	0
Gross Profit	-0.56	-0.02	0	0	0
Selling, General & Admin	54.48	47.26	28.62	6.29	2.29
Research & Development	47.76	46.2	32.66	21.25	10.48
Operating Expenses	102.24	93.46	61.28	27.53	12.77
Operating Income	-102.8	-93.49	-61.28	-27.53	-12.77
Interest Expense / Income	1.1	0.76	0.85	0.72	0.02
Other Expense / Income	-9.08	-3.37	36.65	-0.31	-0.46
Pretax Income	-94.82	-90.88	-98.77	-27.95	-12.32
Net Income	-94.82	-90.88	-98.77	-27.95	-12.32
Shares Outstanding (Basic)	73	71	47	11	9
Shares Outstanding (Diluted)	73	71	47	11	9
Shares Change	2.32%	51.30%	344.62%	22.69%	-
EPS (Basic)	-1.30	-1.28	-2.10	-2.64	-1.43
EPS (Diluted)	-1.30	-1.28	-2.10	-2.64	-1.43
Free Cash Flow	-74.62	-93.12	-56.57	-26.25	-12.2
Free Cash Flow Per Share	-1.02	-1.31	-1.20	-2.48	-1.42
Gross Margin	-19.17%	-3.14%	-	-	-
Operating Margin	-3531.47%	-12220.52%	-	-	-
Profit Margin	-3257.30%	-11879.61%	-	-	-
Free Cash Flow Margin	-2563.28%	-12172.03%	-	-	-
EBITDA	-86.5	-84.08	-96.79	-26.59	-11.96
EBITDA Margin	-2971.35%	-10991.37%	-	-	-
Depreciation & Amortization	7.22	6.03	1.13	0.64	0.35
EBIT	-93.72	-90.12	-97.93	-27.23	-12.31
EBIT Margin	-3219.48%	-11779.87%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).